Data as of Sep 29, 2026 · Based on 74 AI responses · See how Parse measures this
Nova In Silico provides a collaborative clinical trial simulation platform called jinkō that predicts clinical outcomes before human trials. The platform combines data science, biology, and medicine to reduce trial duration, risk, and burden through virtual patient simulations.
0%No change
of AI answers about Nova In Silico and its rivals. Week of Sep 21
“Nova In Silico Synthetic control arms can do more than reduce the time, costs, and practical and ethical hurdles of clinical trials.”
“Nova In Silico (JINKŌ®) : A platform that enables drug developers to simulate virtual populations and control arms”
Excerpts where Nova In Silico appeared in the AI's answer
Nova In Silico Synthetic control arms can do more than reduce the time, costs, and practical and ethical hurdles of clinical trials.
Nova In Silico (JINKŌ®) : A platform that enables drug developers to simulate virtual populations and control arms
AI mentioned Nova In Silico in 0% of answers about Nova In Silico and its rivals in the week of Sep 21.
